Aaron G.L. Fletcher

Insider Reports History

Entity
Individual
Location
40 Guest Street, Boston, MA
Signature
Aaron G.L. Fletcher By: /s/ Daniel Schwarz, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Aaron G.L. Fletcher:

Insider Reports Filed by Aaron G.L. Fletcher

Symbol Company Period Transactions Value $ Form Type Date Filed Role
INAB IN8BIO, INC. Oct 4, 2024 4 $0 4 Oct 11, 2024 10%+ Owner
ACTU ACTUATE THERAPEUTICS, INC. Aug 12, 2024 3 -$200K 4/A Aug 20, 2024 Director, 10%+ Owner
ACTU ACTUATE THERAPEUTICS, INC. Aug 12, 2024 0 $0 4 Aug 14, 2024 Director, 10%+ Owner
ACTU ACTUATE THERAPEUTICS, INC. Aug 12, 2024 56 $3.98M 4 Aug 14, 2024 Director, 10%+ Owner
ACTU ACTUATE THERAPEUTICS, INC. Aug 12, 2024 0 $0 3 Aug 12, 2024 Director, 10%+ Owner
CGTX COGNITION THERAPEUTICS INC Jun 7, 2024 2 $0 4 Jun 11, 2024 Director, 10%+ Owner
LTRN Lantern Pharma Inc. May 23, 2024 6 -$189K 4 May 28, 2024 10%+ Owner
LTRN Lantern Pharma Inc. Feb 27, 2024 9 -$676K 4 Feb 29, 2024 10%+ Owner
LTRN Lantern Pharma Inc. Jan 17, 2024 9 $1.93 4 Jan 19, 2024 10%+ Owner
NGE C IN8BIO, INC. Dec 13, 2023 3 $0 4 Dec 14, 2023 10%+ Owner
LTRN Lantern Pharma Inc. Nov 29, 2023 2 -$500K 4 Dec 1, 2023 10%+ Owner
CGTX COGNITION THERAPEUTICS INC Nov 8, 2023 1 $525K 4 Nov 13, 2023 Director, 10%+ Owner
AZTR Azitra Inc Jun 21, 2023 33 $3M 4 Jun 23, 2023 10%+ Owner
AZTR Azitra Inc Jun 15, 2023 0 $0 3 Jun 15, 2023 10%+ Owner
CGTX COGNITION THERAPEUTICS INC Jun 9, 2023 2 $0 4 Jun 13, 2023 Director, 10%+ Owner
CUE Cue Biopharma, Inc. Jan 3, 2023 1 $0 4 Jan 5, 2023 Director
TFFP TFF Pharmaceuticals, Inc. Dec 29, 2022 1 $0 4 Dec 30, 2022 Director
INAB IN8BIO, INC. Dec 12, 2022 3 $186K 4 Dec 13, 2022 Director, 10%+ Owner
CGTX COGNITION THERAPEUTICS INC Nov 28, 2022 3 $42.6K 4 Nov 29, 2022 Director, 10%+ Owner
TFFP TFF Pharmaceuticals, Inc. Nov 22, 2022 2 $50K 4 Nov 23, 2022 Director
CGTX COGNITION THERAPEUTICS INC Nov 16, 2022 3 $99.4K 4 Nov 17, 2022 Director
CGTX COGNITION THERAPEUTICS INC Nov 15, 2022 3 $1.8M 4 Nov 16, 2022 Director
LTRN Lantern Pharma Inc. Nov 8, 2022 5 -$1.54M 4 Nov 9, 2022 10%+ Owner
INAB IN8BIO, INC. Sep 28, 2022 3 $50.5K 4 Sep 29, 2022 Director, 10%+ Owner
LTRN Lantern Pharma Inc. Sep 2, 2022 6 $0.14 4 Sep 7, 2022 10%+ Owner
INAB IN8BIO, INC. Aug 26, 2022 6 $103K 4 Aug 30, 2022 Director, 10%+ Owner
INAB IN8BIO, INC. Aug 17, 2022 3 $96.5K 4 Aug 18, 2022 Director, 10%+ Owner
INAB IN8BIO, INC. Aug 16, 2022 3 $3.37M 4 Aug 17, 2022 Director, 10%+ Owner
CGTX COGNITION THERAPEUTICS INC Jun 10, 2022 3 $0 4/A Jun 30, 2022 Director, 10%+ Owner
CGTX COGNITION THERAPEUTICS INC Jun 10, 2022 3 $0 4 Jun 14, 2022 Director, 10%+ Owner
CUE Cue Biopharma, Inc. May 23, 2022 2 $712K 4 May 25, 2022 Director
TFFP TFF Pharmaceuticals, Inc. May 16, 2022 2 $538K 4 May 17, 2022 Director
TFFP TFF Pharmaceuticals, Inc. Apr 4, 2022 2 $3.5M 4 Apr 4, 2022 Director
CUE Cue Biopharma, Inc. Mar 31, 2022 1 $3.5M 4 Apr 4, 2022 Director
CGTX COGNITION THERAPEUTICS INC Jan 31, 2022 2 $0 4 Feb 1, 2022 Director, 10%+ Owner
CUE Cue Biopharma, Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 Director
SWKH SWK Holdings Corp Dec 31, 2021 1 $0 4 Jan 12, 2022 Director
SWKH SWK Holdings Corp Dec 31, 2021 1 $0 4 Jan 3, 2022 Director
CGTX COGNITION THERAPEUTICS INC Oct 13, 2021 1 $0 4/A Feb 1, 2022 Director, 10%+ Owner
CGTX COGNITION THERAPEUTICS INC Oct 7, 2021 0 $0 3/A Feb 1, 2022 Director, 10%+ Owner
SWKH SWK Holdings Corp Sep 30, 2021 2 $0 4 Oct 1, 2021 Director
INAB IN8BIO, INC. Aug 13, 2021 2 $0 4 Aug 17, 2021 10%+ Owner
INAB IN8BIO, INC. Aug 3, 2021 14 $0 4 Aug 3, 2021 10%+ Owner
INAB IN8BIO, INC. Jul 29, 2021 0 $0 3 Jul 29, 2021 10%+ Owner
SWKH SWK Holdings Corp Jun 30, 2021 1 $0 4 Jun 30, 2021 Director